{"id":27,"date":"2026-06-08T15:19:31","date_gmt":"2026-06-08T13:19:31","guid":{"rendered":"https:\/\/alfakjn.com\/?page_id=27"},"modified":"2026-07-09T10:05:46","modified_gmt":"2026-07-09T08:05:46","slug":"fissures-and-haemorrhoids","status":"publish","type":"page","link":"https:\/\/alfakjn.com\/en\/ragadi-ed-emorroidi\/","title":{"rendered":"Fissures and haemorrhoids"},"content":{"rendered":"
\n \n \n \n\t\n\n
<\/div>\n\n\n

\nFissures and haemorrhoids\n<\/h1>
\n \n \n\t\n\n\n\n

\nA broad and poorly differentiated segment. The Alfakjn proposal is a response with a precise indication.\n<\/h2>
\n

Proctological conditions amenable to conservative treatment, such as haemorrhoids and anal fissures, affect a significant proportion of the adult population, with a market distributed between the prescriptive channel (proctologist, surgeon, general practitioner) and pharmacist advice. It is a segment with continuous demand and high sensitivity to professional advice.<\/p>\n

For the distributor, the area presents a dual-positioning opportunity: in the clinical channel, where the product is prescribed or recommended by the practitioner, and in the pharmacy channel, where the pharmacist plays an active role in selecting the topical treatment. The key to differentiating oneself in this market is to have a product with a clear indication and solid documentation, not yet another generic alternative.<\/p>\n<\/div>\n<\/div><\/div>\n<\/section>

\n \n \n\t\n\n\n\n

\nHemorrhial Plus: precise indication, dual channel\n<\/h2>
\n
\n \"Alfakjn\n<\/div>\n
\n

Hemorrhial Plus<\/h3>\n \n

Medical device for the topical treatment of haemorrhoids and anal fissures. Formulation designed to reduce acute symptoms and support tissue healing, with a safety profile suitable for continuous use.<\/p>

For the distributor<\/strong>: product with a defined therapeutic indication and a clear positioning for both the prescribing professional and the pharmacist. Its direct topical action and available clinical documentation make it suitable for conservative protocols prior to any surgical approaches.<\/p> <\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\n
\n \"Alfakjn\n<\/div>\n
\n

Hemorrhial Plus<\/h3>\n \n

Medical device for the topical treatment of haemorrhoids and anal fissures. Formulation designed to reduce acute symptoms and support tissue healing, with a safety profile suitable for continuous use.<\/p>

For the distributor<\/strong>: product with a defined therapeutic indication and a clear positioning for both the prescribing professional and the pharmacist. Its direct topical action and available clinical documentation make it suitable for conservative protocols prior to any surgical approaches.<\/p> <\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\nDUAL REFERENCE CHANNEL\n<\/h3>
\n

Hemorrhial Plus positions itself at the intersection of prescription and professional advice:<\/p>\n